東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Shape Dependent Iron Oxide Nanoparti...

Sherwood, Jennifer.

Linked to FindBook

Google Book

Amazon

博客來

Shape Dependent Iron Oxide Nanoparticles for Simultaneous Imaging and Therapy.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Shape Dependent Iron Oxide Nanoparticles for Simultaneous Imaging and Therapy./
Author:	Sherwood, Jennifer.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
Description:	142 p.
Notes:	Source: Dissertations Abstracts International, Volume: 80-04, Section: B.
Contained By:	Dissertations Abstracts International80-04B.
Subject:	Bioengineering. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10838849
ISBN:	9780438443563

Shape Dependent Iron Oxide Nanoparticles for Simultaneous Imaging and Therapy.
Sherwood, Jennifer.

Shape Dependent Iron Oxide Nanoparticles for Simultaneous Imaging and Therapy. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 142 p.

Source: Dissertations Abstracts International, Volume: 80-04, Section: B.

Thesis (Ph.D.)--The University of Alabama, 2018.

This item must not be sold to any third party vendors.

The primary focus of this dissertation is to explore the use of shape dependent iron oxide nanoparticles as magnetic resonance imaging contrast agents. In addition to biocompatibility, nanoparticles provide a foundation for implementing imaging guided drug delivery systems. We begin with the synthesis of iron oxide nanoparticles of varying sizes and shapes. Specifically, large (> 4 nm) spherical particles, ultrasmall (< 4 nm) nanoparticles, and ultrathin (2x20 nm) nanowires were synthesized by thermal decomposition of an iron oleate precursor. To render the nanoparticles biologically compatible, a phase transfer step was necessary to transfer nanoparticles from organic solvents aqueous phase. Insufficient or incomplete ligand exchange of the ultrasmall nanoparticles could result in aggregation and a loss of the paramagnetic properties. Here we were able to successfully coat the nanoparticles with several biologically compatible ligands while maintaining the paramagnetic properties for T1 MRI contrast agents. Furthermore, we explored the cellular uptake behaviors of the subnanometer ultrasmall nanoparticles and ultrathin nanowires. The nanoparticles were functionalized with tannic acid and incubated with HepG2 cells. The shape dependent cellular uptake was quantified, and the ultrasmall nanoparticles exhibited a much higher cellular uptake than the ultrathin nanowires. The high cellular uptake of the ultrasmall nanoparticles may be ideal for stem cell labelling, however the low blood circulation time (< 15 min) limited their use, in vivo. In order to increase the circulation time, the size must be increased without altering the magnetic properties of the nanoparticles. Therefore, the ultrasmall nanoparticles were trapped in a bovine serum albumin matrix using protein desolvation. Using the protein matrix, nanoparticles were clustered together, free from aggregation, in a water rich environment allowing for the clusters to maintain the positive, T1 contrast. Encapsulation of the nanoparticles in proteins increased the in vivo blood circulation time from 15 min to over 2 hours. Finally, we demonstrated that both small molecule and protein drugs may be loaded into the clusters. The drug loading and release was studied using fluorescent dyes as a model. The drugs could be released through two mechanisms, enzymatic degradation, or physically released using ultrasound. These studies open up the possibility to both deliver drugs to targeted locations, as well as monitor the distribution, localization, and release of the drugs, noninvasively, in vivo, using MRI.

ISBN: 9780438443563Subjects--Topical Terms:

657580
Bioengineering.

Shape Dependent Iron Oxide Nanoparticles for Simultaneous Imaging and Therapy.
LDR:03702nmm a2200337 4500 001 2209502
005 20191105130500.5
008 201008s2018 ||||||||||||||||| ||eng d
020 $a 9780438443563
035 $a (MiAaPQ)AAI10838849
035 $a (MiAaPQ)alatus:13618
035 $a AAI10838849
040 $a MiAaPQ $c MiAaPQ
100 1 $a Sherwood, Jennifer. $3 3436592
245 1 0 $a Shape Dependent Iron Oxide Nanoparticles for Simultaneous Imaging and Therapy.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 142 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-04, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Bao, Yuping.
502 $a Thesis (Ph.D.)--The University of Alabama, 2018.
506 $a This item must not be sold to any third party vendors.
520 $a The primary focus of this dissertation is to explore the use of shape dependent iron oxide nanoparticles as magnetic resonance imaging contrast agents. In addition to biocompatibility, nanoparticles provide a foundation for implementing imaging guided drug delivery systems. We begin with the synthesis of iron oxide nanoparticles of varying sizes and shapes. Specifically, large (> 4 nm) spherical particles, ultrasmall (< 4 nm) nanoparticles, and ultrathin (2x20 nm) nanowires were synthesized by thermal decomposition of an iron oleate precursor. To render the nanoparticles biologically compatible, a phase transfer step was necessary to transfer nanoparticles from organic solvents aqueous phase. Insufficient or incomplete ligand exchange of the ultrasmall nanoparticles could result in aggregation and a loss of the paramagnetic properties. Here we were able to successfully coat the nanoparticles with several biologically compatible ligands while maintaining the paramagnetic properties for T1 MRI contrast agents. Furthermore, we explored the cellular uptake behaviors of the subnanometer ultrasmall nanoparticles and ultrathin nanowires. The nanoparticles were functionalized with tannic acid and incubated with HepG2 cells. The shape dependent cellular uptake was quantified, and the ultrasmall nanoparticles exhibited a much higher cellular uptake than the ultrathin nanowires. The high cellular uptake of the ultrasmall nanoparticles may be ideal for stem cell labelling, however the low blood circulation time (< 15 min) limited their use, in vivo. In order to increase the circulation time, the size must be increased without altering the magnetic properties of the nanoparticles. Therefore, the ultrasmall nanoparticles were trapped in a bovine serum albumin matrix using protein desolvation. Using the protein matrix, nanoparticles were clustered together, free from aggregation, in a water rich environment allowing for the clusters to maintain the positive, T1 contrast. Encapsulation of the nanoparticles in proteins increased the in vivo blood circulation time from 15 min to over 2 hours. Finally, we demonstrated that both small molecule and protein drugs may be loaded into the clusters. The drug loading and release was studied using fluorescent dyes as a model. The drugs could be released through two mechanisms, enzymatic degradation, or physically released using ultrasound. These studies open up the possibility to both deliver drugs to targeted locations, as well as monitor the distribution, localization, and release of the drugs, noninvasively, in vivo, using MRI.
590 $a School code: 0004.
650 4 $a Bioengineering. $3 657580
650 4 $a Nanotechnology. $3 526235
650 4 $a Materials science. $3 543314
690 $a 0202
690 $a 0652
690 $a 0794
710 2 $a The University of Alabama. $b Chemical & Biological Engineering. $3 1680275
773 0 $t Dissertations Abstracts International $g 80-04B.
790 $a 0004
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10838849